PRESS RELEASE published on 01/18/2024 at 14:00, 2 years 2 months ago Visalaw.Ai Launches GEN 1.0: A Revolutionary AI-Powered Legal Research Tool for Immigration Law Firms Visalaw.Ai, a leading technology firm in the legal sector, has announced the launch of GEN 1.0, a revolutionary legal research product tailored to immigration law firms, powered by AILA resources. GEN 1.0 offers unique content, leverages OpenAI's GPT-4, prioritizes privacy and security, and provides user-managed data. Designed for lawyers, it facilitates team collaboration and offers transparent pricing. For more information or to request access, visit Visalaw.Ai. Visalaw.Ai GEN 1.0 Immigration Law Firms Legal Research AILA Resources
Published on 04/09/2026 at 19:15, 52 minutes ago Murchison Minerals Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
Published on 04/09/2026 at 16:00, 4 hours 7 minutes ago Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 5 hours 27 minutes ago Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 6 hours 7 minutes ago Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 6 hours 37 minutes ago Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 18:15, 1 hour 52 minutes ago REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 15:40, 4 hours 27 minutes ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 04/09/2026 at 15:39, 4 hours 28 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 04/09/2026 at 18:35, 1 hour 32 minutes ago Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 15:57, 4 hours 10 minutes ago Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 13 hours 7 minutes ago bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/08/2026 at 18:02, 1 day 2 hours ago Publication of the 2025 Universal Registration Document